LUMARA BIO
"LUMARA BIO" is a word and design mark owned by ITM Isotope Technologies Munich SE, filed at the USPTO on July 1, 2026. It is under examination and covers classes 5, 9, 35, 40, 42, 44 and 45.
- Status
- Under examination
- Since July 1, 2026
- Filed
- July 1, 2026
- Registered
- Not yet
- Priority date
- June 12, 2026
- Claimed from Germany
- Application no.
- 99917836
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word and design
- 7 classes
Who owns LUMARA BIO
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
ITM Isotope Technologies Munich SE
Garching, Germany
Representative
Kari Moyer-Henry
Lewis Kohn & Walker LLP
What the mark covers
The products and services LUMARA BIO is filed for, grouped by Nice class.
Pharmaceutical products; Radiopharmaceuticals; Radiopharmaceutical preparations for diagnostic and therapeutic purposes; Diagnostic preparations and substances for medical purposes; Theranostic preparations for medical purposes; Radioactive pharmaceutical preparations; Radiological contrast agents for medical purposes; Biological preparations for medical purposes; Preparations for oncology; Preparations for nuclear medicine; Radioligands for medical purposes; Radioisotope-containing preparations for medical use; Radioactive isotopes for medical purposes; Medical radionuclides; Intermediates and starting materials for the manufacture of radiopharmaceuticals; Pharmaceutical and radiopharmaceutical active ingredients; Preparations for medical imaging.
Downloadable software for medical imaging; Software for processing, visualizing, and interpreting diagnostic image data; Software for treatment planning and clinical decision support in oncology and nuclear medicine; Artificial intelligence software for medical diagnostics and imaging; Software for theranostics; Medical image analysis software; Scientific apparatus and instruments for the analysis of radiopharmaceutical data; Downloadable computer programs for medical diagnostics; Electronic databases in the fields of medicine and pharmacy, whether recorded or downloadable; Software for precision medicine; Software for clinical data analysis; Software for managing radiopharmaceutical production and supply chains; Software for the management and analysis of medical and scientific data; Applications for cloud computing and data-driven medical decision support
Business consulting in the fields of pharmaceuticals, radiopharmaceuticals, and healthcare; Management and corporate administration for pharmaceutical and medical companies; Marketing, advertising, and sales promotion for pharmaceutical products; Commercial consulting in the fields of radiopharmaceuticals and theranostics; Organization and conduct of trade fairs, conferences, and exhibitions for commercial or promotional purposes; Procurement services for pharmaceutical products; Business brokerage and facilitation of commercial partnerships in the healthcare and pharmaceutical sectors; Distribution services for pharmaceutical and medical products; Import and export services for pharmaceutical and radiopharmaceutical products; Management of commercial supply chains for radiopharmaceuticals and medical isotopes; Commercial exploitation of intellectual property; Marketing of pharmaceutical technologies, patents, know-how, and innovations; Consulting regarding the commercialization of scientific research results.
Manufacture of radiopharmaceuticals; Contract manufacturing of radiopharmaceuticals for third parties; Custom manufacturing of pharmaceutical and radiopharmaceutical products; Production of medical isotopes and radionuclides; Processing of radioactive materials for medical purposes; Irradiation services for medical and pharmaceutical purposes; Manufacture of diagnostic and therapeutic preparations using radioactive isotopes; Technical production services in the field of radiopharmacy and theranostics.
Scientific and technological research in the fields of radiopharmaceuticals, molecular imaging, nuclear medicine, and theranostics; Pharmaceutical research and development; Research and development of diagnostic and therapeutic agents; Radiochemical research services; Clinical research and the conduct of clinical trials; Development and design of medical imaging technologies and analytical methods; Development of software for medical imaging, diagnostics, and treatment planning; Scientific research in the fields of oncology, cardiology, neurology, and rare diseases; Development and manufacture of radiopharmaceuticals on behalf of third parties; Scientific consulting and information services in the field of radiopharmaceuticals and theranostics; Quality control and quality testing of pharmaceutical products; Technological consulting services in the healthcare and pharmaceutical sectors; Software as a Service (SaaS) for medical diagnostics, imaging, treatment planning, and precision medicine; Provision of temporary access to non-downloadable software; Platform as a Service (PasS) for medical data analysis; Hosting of digital platforms for medical, clinical, and scientific data; Cloud-based analysis and decision support systems for the healthcare sector; Provision of online platforms for precision medicine and theranostics; Electronic storage of medical and scientific data; Development and operation of data-driven platforms in healthcare; Research in the field of artificial intelligence for medical diagnostics and therapy; Technology transfer and scientific application of research findings.
Medical services; Diagnostic imaging services, including positron emission tomography (PET) and single-photon emission computed tomography (SPECT); Nuclear medicine services; Oncology services; Provision of theranostic treatments; Medical analysis services for diagnostic and therapeutic purposes; Clinical services related to radiopharmaceuticals; Health counseling regarding diagnosis and treatment; Medical services in the field of precision medicine; Therapeutic services using radioligands; Medical services in the field of molecular imaging.
Licensing of intellectual property; Licensing of patents, know-how, technologies, and scientific developments; Granting and managing rights to use pharmaceutical and radiopharmaceutical technologies; Licensing of software and data platforms; Management of industrial property rights; Legal advice regarding intellectual property and technology transfer
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application entered
About LUMARA BIO
Who owns the trademark "LUMARA BIO"?
The USPTO trademark "LUMARA BIO" (application 99917836) is owned by ITM Isotope Technologies Munich SE.
What is the status of "LUMARA BIO"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull LUMARA BIO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019f22f6-eaaa-7751-8272-a598b240a23b
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019f22f6-eaaa-7751-8272-a598b240a23b",
"object": "trademark",
"mark_text": "LUMARA BIO",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "99917836",
"filing_date": "2026-07-01",
"nice_classes": [
5,
9,
35,
40,
42,
44,
45
],
"owners": [
{
"name": "ITM Isotope Technologies Munich SE",
"entity_id": "ent_019eb710-15d5-730b-9a08-f8d3d27272b9"
}
]
}